Sex differences between CRF1 receptor deficient mice following naloxone-precipitated morphine withdrawal in a conditioned place aversion paradigm: Implication of HPA axis

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  García Carmona, Juan Antonio ^a   Baroja Mazo, Alberto ^b   Milanés, María Victoria ^a   Laorden, María Luisa ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; NALOXONE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; MORPHINE; NARCOTIC ANTAGONIST;

ADULT; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; AVERSIVE BEHAVIOR; BODY WEIGHT; CONDITIONED PLACE AVERSION PARADIGM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; EXPERIMENTAL TEST; FEMALE; GENOTYPE; HABITUATION; HETEROZYGOSITY; HOMOZYGOSITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; SEX DIFFERENCE; WEIGHT GAIN; WEIGHT REDUCTION; WITHDRAWAL SYNDROME; ANIMAL; BLOOD; DEFICIENCY; DRUG EFFECTS; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALIA; MUS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BODY WEIGHT; CORTICOSTERONE; FEMALE; GENOTYPE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MICE, KNOCKOUT; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84926483184     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121125     Document Type: Article

References (55)

1. Hildebrand ER, Lasek AW. Sex differences in cocaine conditioned place preference in C57BL/6J mice. NeuroReport. 2014; 25:105-109. doi: 10.1097/WNR.0000000000000053 PMID: 24145777
2. Anker JJ, Carroll ME. Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci. 2010; 8: 73-96. doi: 10.1007/ 7854-2010-93 PMID: 21769724
3. Becker JB, Hu M. Sex differences in drug abuse. Front Neuroendocrin. 2008; 29: 36-47. PMID: 17904621
4. Carroll ME, Anker JJ. Sex differences and ovarian hormones in animal models of drug dependence. Horm Behav. 2010; 58: 44-56. doi: 10.1016/j.yhbeh.2009.10.001 PMID: 19818789
5. Carroll ME, Lynch WJ, Roth ME, Morgan AD. Sex and estrogen influence drug abuse. Trends Pharmacol Sci. 2004; 25: 273-279. PMID: 15120494
6. Devaud LL, Chadda R. Sex differences in rats in the development of and recovery from ethanol dependence assessed by changes in seizure susceptibility. Alcohol Clin Exp Res. 2001; 25: 1689-1696. PMID: 11707644
7. Cicero TJ, Nock B, Meyer ER. Gender-linked differences in the expression of physical dependence in the rat. Pharmacol Biochem Behav. 2002; 72: 691-697. PMID: 12175466
8. Suzuki T, Koike Y, Yoshii T, Yanaura S. Sex differences in the induction of physical dependence on pentobarbital in the rat. Jpn J Pharmacol. 1985; 39: 453-459. PMID: 4094188
9. Suzuki T, Koike Y, Misawa M. Sex differences in physical dependence on methaqualone in the rat. Pharmacol. Biochem Behav. 1988; 30: 483-488. PMID: 3174779
10. Perry JL, Normile LM, Morgan AD, Carroll ME. Sex differences in physical dependence on orally selfadministered phencyclidine (PCP) in rhesus monkeys (Macaca mulatta). Exp Clin Psychopharmacol. 2006; 14: 68-78. PMID: 16503706
11. Deshmukh A, O'Reilly A, Pfefferbaum A, Rosenboom MJ, Sassoon S, Sullivan EV. Alcoholic men endorse more DSM-IV withdrawal symptoms than alcoholic women matched in drinking history. J Stud Alcohol. 2003; 64: 375-379. PMID: 12817826
12. Kest B, Palmese CA, Hopkins E, Adler M, Juni A. Assessment of acute and chronic morphine dependence in male and female mice. Pharmacol Biochem Behav. 2001; 70: 149-156. PMID: 11566152
13. Radke AK, Hotz NA, Gewirtz ME, Carroll ME. Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake. Psychopharmacology. 2013; 227: 117-126. doi: 10.1007/s00213-012-2945-0 PMID: 23254375
14. Radke AK, Gewirtz JC. Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal. Psychopharmacology. 2012; 37: 2405-2415.
15. Tzschentke TM. Review on CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol. 2007; 12: 227-262. PMID: 17678505
16. Ueno K, Maeda T, Kiguchi N, Kobayashi Y, Ozaki M, Kishioka S. Availability of serum corticosterone level for quantitative evaluation of morphine withdrawal in mice. Drug Discover Ther. 2011; 5: 71-75
17. Contarino A, Papaleo F. The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal. Proc Natl Acad Sci USA. 2005; 102: 18649-18654 PMID: 16339307
18. Harris GC, Aston-Jones G. Activation in extended amygdale corresponds to alter hedonic processing during protracted morphine withdrawal. Behav Brain Res. 2007; 176: 251-258 PMID: 17123639
19. Papaleo F, Kitchener P, Contarino A. Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal. Neuron 2007; 53: 577-589. PMID: 17296558
20. Koob GF. A role for brain stress system in addiction. Neuron. 2008; 59: 11-34. doi: 10.1016/j.neuron. 2008.06.012 PMID: 18614026
21. De Souza EB. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendrocrinology. 1995; 20: 789-819.
22. Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviours. Annu Rev Pharmacol Toxicol. 2004; 44: 525-557. PMID: 14744257
23. Korosi A, Veening JG, Kozicz T, Henckens M, Dederen J, Groenink L. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain. Brain Res. 2006; 1072: 46-55. PMID: 16423327
24. Bruijnzeel AW, Prado M, Isaac S. Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biol Psychiatry. 2009; 66: 110-117. doi: 10.1016/j.biopsych.2009.01.010 PMID: 19217073
25. Koob GF. The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res. 2010; 1314: 3-14. doi: 10.1016/j.brainres.2009.11.008 PMID: 19912996
26. Goeldner C, Lutz P-E, Darcq E, Alter T, Clesse D, Ouagazzal A-M, et al. Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine. Biol Psychiatry. 2011; 69: 236-244. doi: 10.1016/j.biopsych.2010.08.021 PMID: 20947067
27. Liang D, Shi X, Li X, Li J, Clark JD. Chronic pain and genetic background interact and influence opioid analgesia, tolerance, and physical dependence. Pain 2006; 121: 232-240. PMID: 16516386
28. Liang DY, Guo T, Liao G, Kingeri WS, Peltz G, Clark JD. The beta2 adrenergic regulates morphine tolerance and physical dependence. Behav Brain Res. 2007; 81: 118-126.
29. Ziólkowska B, Korostyñski M, Piechota M, Kubik J, Przewlocki R. Effects of morphine on immediateearly gene expression in the striatum of C57BL/6J and DBA/2J mice. Pharmacological Reports. 2012; 64, 1091-1104. PMID: 23238466
30. Martínez-Laoden E, García-Carmona JA, Baroja-Mazo A, Romecín P, Atucha N, Milanés MV, et al. Corticotropin-releasing factor (CRF) receptor-1 is involved in cardiac noradrenergic activity observed during naloxone-precipitated morphine withdrawal. Br J Pharmacol. 2014; 171: 688-700. doi: 10.1111/ bph.12511 PMID: 24490859
31. Garcia-Carmona JA, Almela P, Baroja-Mazo A, Milanes MV, Laorden ML. Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal. Psychopharmacology. 2012; 220: 379-393 doi: 10.1007/s00213-011-2478-y PMID: 21947312
32. Valverde O, Fournie-Zaluski MC, Roques BP, Maldonado R. The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats. Psychopharmacology. 1996; 123: 119-126 PMID: 8741934
33. Gómez-Milanés I, Almela P, García-Carmona JA, García-Gutiérrez MS, Aracil-Fernández A, Manzanares J, et al. Accumbal dopamine, noradrenaline and serotonin activity after naloxone-conditioned place aversion in morphine-dependent mice. Neurochem Int. 2012; 61: 433-440 doi: 10.1016/j.neuint. 2012.06.011 PMID: 22713675
34. Sharf R, Sarhan M, Dileone RJ. Role of orexin/hypocretin in dependence and addiction. Brain Res. 2010; 1314: 130-138. doi: 10.1016/j.brainres.2009.08.028 PMID: 19699189
35. Berhow MT, Russel DS, Terwilliger RZ, Beitner-Johnson D, Self DW, Lindsay RM, et al. Influence of neurotrophic factors on morphine-and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neurosci. 1995; 68: 969-979.
36. Wu P, Shi H-S, Luo Y-X, Zhang R-Y, Li J-L, Shi J, et al. Neuropeptide trefoil factor attenuates naloxoneprecipitate withdrawal in morphine-dependent mice. Psychopharmacology. 2014; 231: 4659-4668. doi: 10.1007/s00213-014-3615-1 PMID: 24825609
37. Diaz SL, Kemmling AK, Rubio MC, Balerio GN. Lack of sex-related differences in the prevention by baclofen of the morphine withdrawal syndrome in mice. Behav Pharmacol. 2001; 12: 75-79. PMID: 11270515
38. Craft RM, Stratmann JA, Bartok RE, Walpole TI, King SJ. Sex differences in development of morphine tolerance and dependence in the rat. Psychopharmacology (Berl) 1999; 143: 1-7.
39. Papaleo F, Contarino A. Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice. Behav Brain Res. 2006; 170: 110-118. PMID: 16580078
40. Navarro-Zaragoza J, Nuñez C, Laorden ML, Milanés MV. Effects of corticotropin-releasing factor recep-tor-1 antagonists on the brain stress system response to morphine withdrawal. Mol Pharmacol. 2010; 77: 864-873. doi: 10.1124/mol.109.062463 PMID: 20159948
41. Iredale PA, Alvaro JD, Lee Y, Terwilliger R, Chen YL, Duman RS. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal. J Neurochem. 2000; 74: 199-208. PMID: 10617121
42. Blum K, Eubanks JD, Wiggins B, Wallace JE. Morphine withdrawal reactions in male and female mice. Am J Drug Alcohol Abuse. 1976; 3: 363-368. PMID: 1036445
43. El-Kadi AO, Sharif SI. The influence of various experimental conditions on the expression of naloxoneinduced withdrawal symptoms in mice. Gen Pharmacol. 1994; 25: 1505-1510. PMID: 7896067
44. Miyamoto Y, Takemori AE. Relative involvement of supraspinal and spinal mu opioid receptors in morphine dependence in mice. Life Sci. 1993; 52:1039-1044. PMID: 8383266
45. Way EL, Lou HH, Shen FH. Simultaneous quantitative assessment of morphine tolerance and physical dependence. J Pharmacol Exp Ther. 1969; 167: 1-8. PMID: 5814495
46. Brandao ML. Involvement of opioid mechanisms in the dorsal periaqueductal gray in drug abuse. Rev Neurosci. 1993; 4: 397-405. PMID: 8275278
47. Koob GF, Maldonado R, Stinus L. Neural substrates of opiate withdrawal. Trends Neurosci. 1992; 15: 186-191. PMID: 1377426
48. Budzynska B, Polak P, Biala G. Effects of calcium channel antagonists on the motivational effects of nicotine and morphine in conditioned place aversion. Beh Brain Res. 2012; 228: 144-150. doi: 10. 1016/j.bbr.2011.12.003 PMID: 22178315
49. Feltenstein MW, See RE. NMDA receptor blockade in the basolateral amygdala disrupts consolidation of stimulus-reward memory and extinction learning during reinstatement of cocaine-seeking in an animal model of relapse. Neurobiol Learn Mem. 2007; 88: 435-444. PMID: 17613253
50. Hsu E, Packard MG. Medial prefrontal cortex infusions of bupivacaine or AP-5 block extinction of amphetamine conditioned place preference. Neurobiol Learn Mem. 2008; 89: 504-512. PMID: 17905604
51. Torregrossa MM, Sanchez H, Taylor JR. D-cycloserine reduces the context specificity of pavlovian extinction of cocaine cues through actions in the nucleus accumbens. J Neurosci. 2010; 30: 10526-10533. doi: 10.1523/JNEUROSCI.2523-10.2010 PMID: 20685995
52. Myers KM, Carlezon WA Jr. D-cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats. Biol Psychiatry. 2010; 67: 85-87. doi: 10.1016/j.biopsych.2009. 08.015 PMID: 19782965
53. Solecki W, Turek A, Kubik J, Przewlocki R. Motivational effects of opiates in conditioned place preference and aversion paradigm-a study in three inbred strains of mice. Psychopharmacology. 2009; 207: 245-255. doi: 10.1007/s00213-009-1672-7 PMID: 19787337
54. Bornstein SR, Engeland WC, Ehrhart-Bornstein ME, Herman JP. Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab. 2008; 19: 175-180. doi: 10.1016/j.tem.2008.01.009 PMID: 18394919
55. Choi DC, Furai AR, Evanson NK, Ostrander MM, Ulrich-Lai YM, Herman JP. Bed nucleus of the stria terminalis subregions differentially regulates hypothalamic-pituitary-adrenal axis activity: implications for the integration of limbic inputs. J Neurosci. 2007; 27: 2025-2034. PMID: 17314298